368 related articles for article (PubMed ID: 34021251)
1. JAK2 unmutated erythrocytosis: current diagnostic approach and therapeutic views.
Gangat N; Szuber N; Pardanani A; Tefferi A
Leukemia; 2021 Aug; 35(8):2166-2181. PubMed ID: 34021251
[TBL] [Abstract][Full Text] [Related]
2. JAK2 unmutated erythrocytosis: 2023 Update on diagnosis and management.
Gangat N; Szuber N; Tefferi A
Am J Hematol; 2023 Jun; 98(6):965-981. PubMed ID: 36966432
[TBL] [Abstract][Full Text] [Related]
3. The complete evaluation of erythrocytosis: congenital and acquired.
Patnaik MM; Tefferi A
Leukemia; 2009 May; 23(5):834-44. PubMed ID: 19295544
[TBL] [Abstract][Full Text] [Related]
4. Molecular study of congenital erythrocytosis in 70 unrelated patients revealed a potential causal mutation in less than half of the cases (Where is/are the missing gene(s)?).
Bento C; Almeida H; Maia TM; Relvas L; Oliveira AC; Rossi C; Girodon F; Fernandez-Lago C; Aguado-Diaz A; Fraga C; Costa RM; Araújo AL; Silva J; Vitória H; Miguel N; Silveira MP; Martin-Nuñez G; Ribeiro ML
Eur J Haematol; 2013 Oct; 91(4):361-8. PubMed ID: 23859443
[TBL] [Abstract][Full Text] [Related]
5. Diagnostic Performance of Erythropoietin Levels in Polycythemia Vera: Experience at a Comprehensive Cancer Center.
Davila-Gonzalez D; Barrios-Ruiz A; Fountain E; Cheng L; Masarova L; Verstovsek S; Rojas-Hernandez CM
Clin Lymphoma Myeloma Leuk; 2021 Apr; 21(4):224-229. PubMed ID: 33349602
[TBL] [Abstract][Full Text] [Related]
6. Diagnostic Approaches to Investigate JAK2-Unmutated Erythrocytosis Based on a Single Tertiary Center Experience.
Lee Y; Seo SH; Kim J; Kim SA; Lee JY; Lee JO; Bang SM; Park KU; Hwang SM
Mol Diagn Ther; 2024 May; 28(3):311-318. PubMed ID: 38568469
[TBL] [Abstract][Full Text] [Related]
7. Hereditary erythrocytosis, thrombocytosis and neutrophilia.
Hong WJ; Gotlib J
Best Pract Res Clin Haematol; 2014 Jun; 27(2):95-106. PubMed ID: 25189721
[TBL] [Abstract][Full Text] [Related]
8. Idiopathic erythrocytosis: a disappearing entity.
McMullin MF
Hematology Am Soc Hematol Educ Program; 2009; ():629-35. PubMed ID: 20008248
[TBL] [Abstract][Full Text] [Related]
9. Polycythemia vera: scientific advances and current practice.
Tefferi A; Spivak JL
Semin Hematol; 2005 Oct; 42(4):206-20. PubMed ID: 16210034
[TBL] [Abstract][Full Text] [Related]
10. Clinical features of acquired erythrocytosis: Low levels of serum erythropoietin in a subset of non-neoplastic erythrocytosis patients.
Mori Y; Araki M; Morishita S; Imai M; Edahiro Y; Ito M; Ochiai T; Shirane S; Hashimoto Y; Yasuda H; Ando J; Ando M; Komatsu N
Cancer Med; 2023 Jan; 12(2):1079-1089. PubMed ID: 35775283
[TBL] [Abstract][Full Text] [Related]
11. The clinical and laboratory evaluation of the patient with erythrocytosis.
Lee G; Arcasoy MO
Eur J Intern Med; 2015 Jun; 26(5):297-302. PubMed ID: 25837692
[TBL] [Abstract][Full Text] [Related]
12. [Systematic diagnosis of erythrocytosis].
de Heer K; Silbermann MH; Koene HR; Biemond BJ; Muller HP; van Oers MH
Ned Tijdschr Geneeskd; 2007 Aug; 151(32):1770-6. PubMed ID: 17822247
[TBL] [Abstract][Full Text] [Related]
13. Two Novel Genetic Variants Involved in the Oxygen Sensing Pathway in JAK2-unmutated Erythrocytosis.
Ma Q; Hu R; Hui W; Zhao H; Zou D; Liu Y; Sun W
Biochem Genet; 2024 Apr; ():. PubMed ID: 38568374
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of "increased" hemoglobin in the JAK2 mutations era: a diagnostic algorithm based on genetic tests.
Tefferi A; Pardanani A
Mayo Clin Proc; 2007 May; 82(5):599-604. PubMed ID: 17493421
[TBL] [Abstract][Full Text] [Related]
15. Idiopathic erythrocytosis: a study of a large cohort with a long follow-up.
Randi ML; Bertozzi I; Cosi E; Santarossa C; Peroni E; Fabris F
Ann Hematol; 2016 Jan; 95(2):233-7. PubMed ID: 26547864
[TBL] [Abstract][Full Text] [Related]
16. Polycythemia vera and essential thrombocythemia: 2017 update on diagnosis, risk-stratification, and management.
Tefferi A; Barbui T
Am J Hematol; 2017 Jan; 92(1):94-108. PubMed ID: 27991718
[TBL] [Abstract][Full Text] [Related]
17. Algorithmic evaluation of hereditary erythrocytosis: Pathways and caveats.
Oliveira JL
Int J Lab Hematol; 2019 May; 41 Suppl 1():89-94. PubMed ID: 31069987
[TBL] [Abstract][Full Text] [Related]
18. [How I manage polycythemia].
Lombardo G; Hafraoui K; Beguin Y; Vertenoeil G
Rev Med Liege; 2024 Feb; 79(2):110-115. PubMed ID: 38356428
[TBL] [Abstract][Full Text] [Related]
19. Germline JAK2 E846D Substitution as the Cause of Erythrocytosis?
Maaziz N; Garrec C; Airaud F; Bobée V; Contentin N; Cayssials E; Rimbert A; Aral B; Bézieau S; Gardie B; Girodon F
Genes (Basel); 2023 May; 14(5):. PubMed ID: 37239426
[TBL] [Abstract][Full Text] [Related]
20. The frequency of JAK2 exon 12 mutations in idiopathic erythrocytosis patients with low serum erythropoietin levels.
Percy MJ; Scott LM; Erber WN; Harrison CN; Reilly JT; Jones FG; Green AR; McMullin MF
Haematologica; 2007 Dec; 92(12):1607-14. PubMed ID: 18055983
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
